Propranolol and hair loss is a concern raised by many patients taking this widely prescribed beta-blocker in the UK. Propranolol is used to treat hypertension, angina, anxiety, migraine prevention, and cardiac arrhythmias, but like most long-term medicines, it carries potential side effects. Alopecia is listed in the UK Summary of Product Characteristics (SmPC) for propranolol-containing products, though it is classified as rare or of unknown frequency. Understanding whether propranolol is truly responsible for hair thinning — and what steps to take — requires careful clinical assessment, as many other conditions can cause similar symptoms.

Can Propranolol Cause Hair Loss?

Yes, propranolol can cause hair loss; alopecia is listed as an adverse effect in UK SmPCs, most commonly as telogen effluvium — a diffuse, temporary shedding that is generally reversible once the trigger is addressed.

Experiencing these side effects? Our pharmacists can help you navigate them →

Propranolol is a non-selective beta-blocker widely prescribed in the UK for conditions including hypertension, angina, anxiety, migraine prevention, and certain cardiac arrhythmias. Like many long-term medications, it carries a range of potential side effects — and hair loss, known clinically as alopecia, is one that appears in its UK prescribing information.

Alopecia is listed as an adverse effect in the Summary of Product Characteristics (SmPC) for propranolol-containing medicines available through the MHRA and the Electronic Medicines Compendium (EMC). Depending on the specific licensed product, the frequency is categorised as either 'rare' or 'frequency not known'. It is important to note that the presence of hair loss in a patient taking propranolol does not automatically confirm a causal relationship. Hair thinning can result from numerous factors, including thyroid dysfunction, nutritional deficiencies, hormonal changes, stress, and other concurrent medications. A thorough clinical assessment is therefore essential before attributing hair loss solely to propranolol. Diagnosis is typically made or excluded in primary care, with referral to dermatology if there is diagnostic uncertainty or if red flags are present.

The type of hair loss most commonly associated with beta-blockers, including propranolol, is telogen effluvium — a diffuse, temporary shedding of hair rather than the patchy or permanent loss seen in conditions such as alopecia areata or androgenetic alopecia. Telogen effluvium typically presents as increased hair shedding across the scalp, often noticed on pillows, in the shower, or when brushing. It is generally reversible once the underlying trigger is addressed. Patients who suspect their hair loss may be linked to propranolol should raise this with their GP or prescribing clinician rather than stopping the medication abruptly, as sudden discontinuation of beta-blockers can carry cardiovascular risks.

How Common Is Hair Loss as a Side Effect?

Hair loss is classified as 'rare' (fewer than 1 in 1,000) or 'frequency not known' in UK SmPCs for propranolol, with a typical latency of two to four months between starting the drug and noticeable shedding.

Not sure if this is normal? Chat with one of our pharmacists →

Alopecia is listed in UK SmPCs for propranolol; depending on the specific licensed product, the frequency is reported as either rare (affecting fewer than 1 in 1,000 people) or frequency not known (cannot be estimated from available data). Patients should check the patient information leaflet supplied with their specific product for the applicable wording. While these figures may offer some reassurance, rare or poorly quantified side effects can still be clinically significant for the individuals who experience them.

It is also worth considering that the true incidence of drug-induced hair loss may be underreported. Patients do not always associate hair thinning with a medication they have been taking for some time, particularly if the shedding begins weeks or even months after starting treatment. Telogen effluvium, the form most commonly linked to propranolol, typically has a latency period of two to four months between the triggering event (in this case, the introduction of the drug) and the onset of noticeable hair loss. This delay can make it difficult for both patients and clinicians to identify the connection.

Hair loss has also been reported with other beta-blockers, including metoprolol and atenolol, based on case reports and spontaneous pharmacovigilance data. There are no robust head-to-head comparative trials, so it is not possible to conclude that propranolol carries a meaningfully higher or lower risk of alopecia than other agents in the same class. If hair loss is a particular concern, a prescribing clinician may consider whether an alternative medication class is appropriate for the patient's underlying condition, though this decision must always be guided by clinical need and individual risk–benefit assessment.

Why Beta-Blockers May Affect Hair Growth

Propranolol may disrupt hair follicle cycling by blocking beta-adrenergic receptors present in follicles and reducing peripheral blood flow, though neither mechanism has been confirmed in clinical studies.

To understand why propranolol might contribute to hair loss, it is helpful to consider the hair growth cycle. Hair follicles cycle through three phases: anagen (active growth), catagen (transition), and telogen (resting and shedding). Under normal circumstances, approximately 85–90% of scalp hairs are in the anagen phase at any given time. When the body experiences physiological stress — whether from illness, surgery, nutritional deficiency, or certain medications — a disproportionate number of follicles can shift prematurely into the telogen phase, resulting in diffuse shedding several months later.

Beta-blockers such as propranolol work by blocking beta-adrenergic receptors, thereby reducing the effects of adrenaline (epinephrine) and noradrenaline on the heart and blood vessels. Beta-adrenergic receptors are also present in hair follicles, and it has been hypothesised that adrenergic signalling plays a role in regulating the hair growth cycle. By interfering with this pathway, propranolol may theoretically disrupt normal follicular cycling, though this mechanism has not been confirmed in clinical studies.

Additionally, propranolol can reduce peripheral blood flow as part of its pharmacological action. It has been proposed that this reduction in cutaneous circulation may impair the delivery of oxygen and nutrients to hair follicles, potentially contributing to premature follicular regression. This too remains a theoretical explanation rather than an established mechanism. The effect is likely multifactorial and may depend on individual genetic predisposition, dose, and duration of treatment. Overall, the precise pathway by which propranolol induces hair loss in susceptible individuals is not fully understood.

What to Do If You Notice Hair Thinning on Propranolol

Speak to your GP before making any changes — never stop propranolol abruptly, as this carries cardiovascular risks; your GP will investigate other causes and consider whether an alternative medication is appropriate.

If you notice increased hair shedding or thinning whilst taking propranolol, the first and most important step is to speak with your GP or prescribing clinician. Do not stop taking propranolol suddenly without medical advice. Abrupt discontinuation of beta-blockers can cause rebound effects, including a rapid increase in heart rate, elevated blood pressure, and in some cases, worsening of angina or other cardiac conditions. Any changes to your medication regimen must be made under clinical supervision.

Your GP will likely begin by ruling out other common causes of hair loss. First-line investigations typically include:

• Full blood count (FBC) to exclude anaemia or other haematological causes

• Ferritin to assess iron stores

• Thyroid function tests (TSH) to exclude thyroid dysfunction

Additional tests — such as vitamin B12, coeliac screen, or androgen levels — may be arranged if clinically indicated based on your history and examination findings. Your GP will also review your full medication list, including over-the-counter supplements, and consider recent physical or emotional stressors.

Seek prompt medical attention or a dermatology referral if you notice any of the following red flags: patchy or rapidly progressive hair loss, scalp redness, scaling, pain or itch, broken hairs, signs of scarring, or hair loss accompanied by systemic symptoms such as fatigue, weight change, or joint pain. These features may suggest a different diagnosis requiring specialist assessment.

If propranolol is identified as the likely cause and the hair loss is significantly affecting your quality of life, your clinician may discuss whether an alternative medication is suitable. For example, a calcium channel blocker may be considered for hypertension, or a selective serotonin reuptake inhibitor (SSRI) for anxiety, in line with NICE guidance — though any switch depends entirely on your individual clinical circumstances.

In many cases, telogen effluvium associated with propranolol is self-limiting. Shedding typically begins two to four months after the triggering event; once the trigger is removed or the body adjusts, recovery usually begins within three to six months, with visible regrowth occurring over six to twelve months. Maintaining a balanced diet rich in protein, iron, and vitamins can support overall hair health during this period, though no specific supplement has been proven to reverse drug-induced telogen effluvium.

If you believe propranolol has caused a side effect, you can report this to the MHRA via the Yellow Card scheme (available at yellowcard.mhra.gov.uk). Reporting helps the MHRA monitor the safety of medicines used in the UK.

Other Propranolol Side Effects to Be Aware Of

Common propranolol side effects include fatigue, cold extremities, bradycardia, sleep disturbances, and gastrointestinal symptoms; it is contraindicated in asthma and can mask hypoglycaemia symptoms in patients with diabetes.

Beyond hair loss, propranolol is associated with a range of other side effects that patients and healthcare professionals should be aware of. Many of these are related to its pharmacological mechanism of blocking beta-adrenergic receptors throughout the body.

Common side effects include:

• Fatigue and lethargy — one of the most frequently reported complaints, often due to reduced cardiac output

• Cold extremities — reduced peripheral circulation can cause cold hands and feet

• Bradycardia — a slower than normal heart rate, which may cause dizziness or light-headedness

• Sleep disturbances and vivid dreams — propranolol is lipid-soluble and crosses the blood–brain barrier, which may contribute to these effects

• Gastrointestinal symptoms — including nausea, diarrhoea, or constipation

Of particular clinical importance, propranolol can mask the symptoms of hypoglycaemia (low blood sugar) — such as tremor and palpitations — in patients with diabetes, and may also prolong the duration of a hypoglycaemic episode. Careful monitoring is therefore essential in this patient group, and patients with diabetes should be made aware of this interaction.

Propranolol is contraindicated in patients with asthma or a history of bronchospasm, as non-selective beta-blockade can precipitate severe bronchospasm. In patients with chronic obstructive pulmonary disease (COPD), non-selective beta-blockers such as propranolol should generally be avoided; if there is a compelling clinical indication, use should be with great caution and under specialist guidance. Patients and clinicians should refer to the BNF monograph and the relevant SmPC for full contraindication and caution listings.

Patients should seek urgent medical attention if they experience:

• Significant shortness of breath or wheezing

• Chest pain or a very slow or irregular heartbeat

• Severe dizziness or fainting

• Signs of heart failure, such as ankle swelling or sudden weight gain

NICE guidance and the British National Formulary (BNF) provide detailed prescribing information for propranolol, and patients are encouraged to read the patient information leaflet supplied with their medication. Any concerns about side effects — including hair loss — should always be discussed with a qualified healthcare professional rather than leading to self-discontinuation of treatment. Suspected side effects can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions